Ensysce Biosciences special meeting canceled again due to lack of quorum; no vote on matters

Ensysce Biosciences, Inc.

Special meeting of stockholders scheduled for December 29, 2023 was not held due to lack of quorum.
No matters were submitted to a vote; company had sought approval for matters related to October 23 Securities Purchase Agreement.
Company must call a meeting every four months until stockholder approval is obtained or notes issued under Agreement are no longer outstanding.
This is the second postponement; the meeting was originally set for December 20, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.